WORLD CONGRESS ON TARGETING METABESITY
HILTON LONDON WEMBLEYLONDON, UK Visit the Venue to read more
It is our pleasure to invite you to participate in a unique and important meeting: The World Congress on Targeting Metabesity (Metabesity2017), which will take place 30-31 October 2017 in London, UK.
The term Metabesity expresses the links among diverse major diseases and conditions to shared metabolic roots. Diabetes, obesity, and cardiovascular diseases, joined by neurodegenerative disorders, cancer, and even the aging process itself, share metabolic and inflammatory provenances.
Metabesity2017 aims at stretch goals to prevent and cure disease and slow the aging process by engaging world-renowned experts, executives, policy makers, and other participants from the fields of metabolic-rooted disorders. The Congress will start with updates of key scientific discoveries that present targets for intervention with multiple modalities ranging from nutritionals, drugs, and biologics to devices, diagnostics and digital health management systems.
The distinctive objective of Metabesity2017 is to devise cross-cutting strategies to leverage impact of this science and technology. The emphasis will extend beyond just identifying, translating, and evaluating these assets to taking on the daunting challenges of commercializing, utilizing, and paying for products that can prevent or reverse metabolic-rooted diseases and may entail long development times.
Metabesity2017 will deliver actionable knowledge in a highly interactive format. Importantly, new understandings and solutions will emerge from this cauldron of scientists, regulatory and corporate decision makers, investors, philanthropists, entrepreneurs, and intellectual property experts.
Metabesity2017 will be of high value to anyone with a responsible role in the life sciences world.
We look forward to seeing you at Metabesity2017 in the metropolitan city of London.
Congress Co-Chair Congress Co-Chair
Alexander Fleming, USA | Congress Co-Chair
Dr. Alexander Fleming received his M.D. and internal medicine training from Emory, fellowship training in endocrinology at Vanderbilt and metabolism at National Institutes of Health, where he was a senior fellow.
Dr. Lawrence Steinman is Professor of Neurology, Neurological Sciences and Pediatrics at Stanford University and Chair of the Stanford Program in Immunology from 2001 to 2011. His research focuses on what provokes relapses and remissions in multiple sclerosis (MS) and in neuromyelitis optica (NMO) and the quest for antigen specific therapy. He is developing a small molecule therapeutic in trials for Huntington’s Disease.
Julia Manning is a social pioneer, writer, campaigner and commentator. Julia studied visual science at City University, became a member of the College of Optometrists in 1991 and specialised in diabetes.
Steven N. Austad is a distinguished professor and department chair in the Department of Biology at the University of Alabama at Birmingham.
Dr. Barzilai is the Director of the Institute for Aging Research at the Albert Einstein College of Medicine and the Director of the Glenn Center for the Biology of Human Aging and of the Nathan Shock Center of excellence in biology of aging.
Professor Sir John Bell GBE, FRS is Regius Professor of Medicine at Oxford University, and Chairman of the Office for the Strategic Coordination of Health Research.
Lars Fugger, MD, Ph.D., is a consultant clinical immunologist at the John Radcliffe Hospital at Oxford University Hospitals and professor of Neuroimmunology at the University of Oxford.
Group registrations not allowed
Accompanying persons not allowed
We don’t accept Online Abstracts
Metabesity2017 has secured rooms at preferential rates at the Hilton London Wembley.
The congress / congress organizer is not represented by any housing/accommodation management service.
Bookings must be made directly with the hotel, or with a legitimate online accommodation website ONLY.
Hilton London Wembley
Metabesity2017 invites the submission of original abstracts for poster presentation only.
All abstracts submitted online will be reviewed by the Metabesity2017 chairpersons. The decision of the chairpersons is final.
Abstracts should be submitted via the on-line submission system; abstracts submitted by fax or email will not be accepted or reviewed.
All abstracts must be submitted and presented in English.
To correct an abstract that has already been submitted or to submit another abstract, please use the log-in and password which you received when you submitted your original abstract. This will enable you to access the previously submitted abstract/s or to submit an additional abstract/s.
Title and Body Title:
Each word should begin with a capital letter with the exception of transition words.
The title is limited to 20 words.
The Abstract body should be no longer than 250 words in total
Please structure your abstract using the following headings:
– Results (if relevant)
After your abstract is submitted, you will be sent an automatic e-mail confirming your successful submission.
If you do not receive this confirmation e-mail, please contact the Congress Organizer at firstname.lastname@example.org
Only the accepted abstracts of fully registered and paid presenters can be included in the final program.
Registration and payment is required by 15 September 2017.
Failure to register and pay by this date will result in your abstract being removed from the program.
Dear Industry Leaders and Friends,
We are excited to announce that The World Congress on Targeting Metabesity (Metabesity2017) which will take place 30-31 October 2017 in London, UK.
The term "Metabesity" expresses the links among diverse major diseases and conditions to shared metabolic roots. Diabetes, obesity, and cardiovascular diseases, joined by neurodegenerative disorders, cancer, and even the aging process itself, share metabolic and inflammatory provenances.
Participants at Metabesity2017 will have the unique opportunity to gain first-hand knowledge from key opinion leaders by scheduling one-on-one meetings during the coffee and lunch breaks at the Congress. Metabesity2017 will be of high value to anyone with a responsible role in the life sciences world.
We look forward to meeting you in London!
Metabesity2017 is the perfect platform to reach your target audience. Join us and take advantage of this unique opportunity to showcase your products to key decision makers and leaders in the industry.
We are pleased to offer the below exhibition opportunities (prices available on request).
Company logo on Congress website with a hyperlink to website of your choice
100 word company profile on the Congress Website
Exhibition space of 6sqm (3x2)
1 Exhibitor badge
Table including 2 chairs and electric point
Congress Organizer , Bioevents